Larimar Therapeutics, Inc. (LRMR)

3.83 0.00 (0.00%) USD  |  NASDAQ  |  Sep 04, 16:00
3.85 +0.02 (+0.52%) Pre-Market: 20:00
More

Larimar Therapeutics SG&A Expense (TTM) : 21.65M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for LRMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 21.65M
March 31, 2026 19.72M
December 31, 2025 18.27M
September 30, 2025 18.18M
June 30, 2025 17.96M
March 31, 2025 18.45M
December 31, 2024 17.61M
September 30, 2024 16.57M
June 30, 2024 15.98M
March 31, 2024 14.81M
December 31, 2023 14.09M
September 30, 2023 13.80M
June 30, 2023 12.97M
March 31, 2023 12.27M
December 31, 2022 12.28M
September 30, 2022 11.85M
June 30, 2022 11.62M
March 31, 2022 12.02M
December 31, 2021 12.07M
September 30, 2021 13.11M
June 30, 2021 13.82M
March 31, 2021 12.87M
December 31, 2020 9.74M
September 30, 2020 5.908M
June 30, 2020 2.492M
Date Value
March 31, 2020 0.00
December 31, 2019 3.646M
September 30, 2019 6.88M
June 30, 2019 10.22M
March 31, 2019 13.57M
December 31, 2018 13.19M
September 30, 2018 12.41M
June 30, 2018 12.18M
March 31, 2018 11.84M
December 31, 2017 12.16M
September 30, 2017 12.91M
June 30, 2017 14.63M
March 31, 2017 16.52M
December 31, 2016 18.29M
September 30, 2016 20.63M
June 30, 2016 21.34M
March 31, 2016 21.53M
December 31, 2015 19.20M
September 30, 2015 16.97M
June 30, 2015 13.71M
March 31, 2015 9.92M
December 31, 2014 8.141M
September 30, 2014 6.06M
June 30, 2014 4.855M
March 31, 2014 4.578M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. 14.87M
Marker Therapeutics, Inc. 4.244M
Rezolute, Inc. 27.48M
Krystal Biotech, Inc. 159.89M
ACADIA Pharmaceuticals, Inc. 620.29M